Fabrication and evaluation of novel quercetin-conjugated Fe₃O₄–β-cyclodextrin nanoparticles for potential use in epilepsy disorder

References

• Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7(1):31. doi:10.1038/nrneurol.2010.17821135885
   PubMed Web of Science ®Google Scholar
• Nieoczym D, Socała K, Raszewski G, Wlaź P. Effect of quercetin and rutin in some acute seizure models in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:50–58. doi:10.1016/j.pnpbp.2014.05.00724857758
   PubMedGoogle Scholar
• Garlich FM, Balakrishnan K, Shah SK, Howland MA, Fong J, Nelson LS. Prolonged altered mental status and bradycardia following pediatric donepezil ingestion. Clin Toxicol. 2014;52(4):291–294. doi:10.3109/15563650.2014.900182
   Web of Science ®Google Scholar
• Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008;25(3):475–516. doi:10.1039/b514294f18497896
   PubMed Web of Science ®Google Scholar
• Cho J-Y, Kim I-S, Jang Y-H, Kim A-R, Lee S-R. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci Lett. 2006;404(3):330–335. doi:10.1016/j.neulet.2006.06.01016806698
   PubMedGoogle Scholar
• Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol. 2012;143(2):383–396. doi:10.1016/j.jep.2012.07.00522820241
   PubMed Web of Science ®Google Scholar
• Baghel SS, Shrivastava N, Baghel RS, Agrawal P, Rajput S. A review of quercetin: antioxidant and anticancer properties. World J Pharm Pharmaceutical Sci. 2012;1(1):146–160.
   Google Scholar
• Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA. Protective effect of quercetin in primary neurons against Aβ (1–42): relevance to Alzheimer’s disease. J Nutr Biochem. 2009;20(4):269–275. doi:10.1016/j.jnutbio.2008.03.00218602817
   PubMed Web of Science ®Google Scholar
• Du G, Zhao Z, Chen Y, et al. Quercetin protects rat cortical neurons against traumatic brain injury. Mol Med Rep. 2018;17(6):7859–7865. doi:10.3892/mmr.2018.880129620218
   PubMedGoogle Scholar
• Türedi S, Yuluğ E, Alver A, Bodur A, İnce İ. A morphological and biochemical evaluation of the effects of quercetin on experimental sciatic nerve damage in rats. Exp Ther Med. 2018;15(4):3215–3224. doi:10.3892/etm.2018.582429545838
   PubMedGoogle Scholar
• Singh T, Kaur T, Goel RK. Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. Neurochem Int. 2017;104:27–33. doi:10.1016/j.neuint.2016.12.02328065794
   PubMedGoogle Scholar
• Sefil F, Kahraman I, Dokuyucu R, et al. Ameliorating effect of quercetin on acute pentylenetetrazole induced seizures in rats. Int J Clin Exp Med. 2014;7(9):2471.25356099
   PubMed Web of Science ®Google Scholar
• Nassiri-Asl M, Moghbelinejad S, Abbasi E, et al. Effects of quercetin on oxidative stress and memory retrieval in kindled rats. Epilepsy Behav. 2013;28(2):151–155. doi:10.1016/j.yebeh.2013.04.01923747498
   PubMed Web of Science ®Google Scholar
• Anwer MK, Al-Mansoor MA, Jamil S, Al-Shdefat R, Ansari MN, Shakeel F. Development and evaluation of PLGA polymer based nanoparticles of quercetin. Int J Biol Macromol. 2016;92:213–219. doi:10.1016/j.ijbiomac.2016.07.00227381585
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Naqvi AA, et al. Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia. Artif Cells Nanomed Biotechnol. 2018;46(4):717–729. doi:10.1080/21691401.2017.133702428604104
   PubMed Web of Science ®Google Scholar
• Nday CM, Halevas E, Jackson GE, Salifoglou A. Quercetin encapsulation in modified silica nanoparticles: potential use against Cu (II)-induced oxidative stress in neurodegeneration. J Inorg Biochem. 2015;145:51–64. doi:10.1016/j.jinorgbio.2015.01.00125634813
   PubMedGoogle Scholar
• Ghosh A, Sarkar S, Mandal AK, Das N. Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One. 2013;8(4):e57735. doi:10.1371/journal.pone.005773523620721
   PubMed Web of Science ®Google Scholar
• Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761–769. doi:10.1038/sj.clpt.610040017957183
   PubMed Web of Science ®Google Scholar
• Gobbo OL, Sjaastad K, Radomski MW, Volkov Y, Prina-Mello A. Magnetic nanoparticles in cancer theranostics. Theranostics. 2015;5(11):1249. doi:10.7150/thno.1154426379790
   PubMed Web of Science ®Google Scholar
• Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm. 2002;28(1):1–13.11858519
   PubMed Web of Science ®Google Scholar
• Hashemian M, Anissian D, Ghasemi-Kasman M, et al. Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79:462–471. doi:10.1016/j.pnpbp.2017.07.02528778407
   PubMed Web of Science ®Google Scholar
• Rishitha N, Muthuraman A. Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish. Life Sci. 2018;199:80–87. doi:10.1016/j.lfs.2018.03.01029522770
   PubMed Web of Science ®Google Scholar
• Laurent S, Bridot J-L, Elst LV, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Future Med Chem. 2010;2(3):427–449. doi:10.4155/fmc.09.16421426176
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Othman SF, Curtis ET, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012;7:1761. doi:10.2147/IJN.S3063122619526
   PubMed Web of Science ®Google Scholar
• Shubayev VI, Pisanic IITR, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev. 2009;61(6):467–477. doi:10.1016/j.addr.2009.03.00719389434
   PubMed Web of Science ®Google Scholar
• Najafabadi RE, Kazemipour N, Esmaeili A, Beheshti S, Nazifi S. Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain. BMC Pharmacol Toxicol. 2018;19(1):59. doi:10.1186/s40360-018-0242-130253803
   PubMedGoogle Scholar
• Amanzadeh E, Esmaeili A, Abadi REN, Kazemipour N, Pahlevanneshan Z, Beheshti S. Quercetin conjugated with superparamagnetic iron oxide nanoparticles improves learning and memory better than free quercetin via interacting with proteins involved in LTP. Sci Rep. 2019;9(1):6876. doi:10.1038/s41598-019-43345-w31053743
   PubMedGoogle Scholar
• Ebrahimpour S, Esmaeili A, Beheshti S. Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats. Int J Nanomed. 2018;13:6311. doi:10.2147/IJN.S177627
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials. 2011;32(7):1890–1905. doi:10.1016/j.biomaterials.2010.11.02821167595
   PubMed Web of Science ®Google Scholar
• Hansen SL, Sperling BB, Sánchez C. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(1):105–113. doi:10.1016/j.pnpbp.2003.09.02614687864
   PubMed Web of Science ®Google Scholar
• Gol M, Ghorbanian D, Hassanzadeh S, Javan M, Mirnajafi-Zadeh J, Ghasemi-Kasman M. Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model. Eur J Pharm Sci. 2017;96:72–83. doi:10.1016/j.ejps.2016.09.01627634580
   PubMed Web of Science ®Google Scholar
• Ahmadian SR, Ghasemi-Kasman M, Pouramir M, Sadeghi F. Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy. Neuropharmacology. 2019;146:117–127. doi:10.1016/j.neuropharm.2018.11.03830503994
   PubMedGoogle Scholar
• Ghorbanian D, Ghasemi-Kasman M, Hashemian M, et al. Myristica fragrans Houtt extract attenuates neuronal loss and glial activation in pentylenetetrazol-induced kindling model. Iran J Pharm Res. 2019;18(2):812–825.
   PubMed Web of Science ®Google Scholar
• Nassiri-Asl M, Hajiali F, Taghiloo M, Abbasi E, Mohseni F, Yousefi F. Comparison between the effects of quercetin on seizure threshold in acute and chronic seizure models. Toxicol Ind Health. 2016;32(5):936–944. doi:10.1177/074823371351860324442347
   PubMed Web of Science ®Google Scholar
• Anissian D, Ghasemi-Kasman M, Khalili-Fomeshi M, et al. Piperine-loaded chitosan-STPP nanoparticles reduce neuronal loss and astrocytes activation in chemical kindling model of epilepsy. Int J Biol Macromol. 2018;107:973–983. doi:10.1016/j.ijbiomac.2017.09.07328939512
   PubMed Web of Science ®Google Scholar
• Kaur H, Patro I, Tikoo K, Sandhir R. Curcumin attenuates inflammatory response and cognitive deficits in experimental model of chronic epilepsy. Neurochem Int. 2015;89:40–50. doi:10.1016/j.neuint.2015.07.00926190183
   PubMed Web of Science ®Google Scholar
• Hsieh H-C, Chen C-M, Hsieh W-Y, Chen C-Y, Liu -C-C, Lin F-H. ROS-induced toxicity: exposure of 3T3, RAW264. 7, and MCF7 cells to superparamagnetic iron oxide nanoparticles results in cell death by mitochondria-dependent apoptosis. J Nanopart Res. 2015;17(2):71. doi:10.1007/s11051-015-2886-8
   Web of Science ®Google Scholar
• Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1(1):5358. doi:10.3402/nano.v1i0.5358
   PubMedGoogle Scholar
• Sabareeswaran A, Ansar EB, Varma PRVH, Mohanan PV, Kumary TV. Effect of surface-modified superparamagnetic iron oxide nanoparticles (SPIONS) on mast cell infiltration: an acute in vivo study. Nanomedicine. 2016;12(6):1523–1533. doi:10.1016/j.nano.2016.02.01827013127
   PubMedGoogle Scholar
• Chen J, Shi M, Liu P, et al. Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery. Biomaterials. 2014;35(4):1240–1248. doi:10.1016/j.biomaterials.2013.10.05724239110
   PubMedGoogle Scholar
• Hu K, Li S-Y, Xiao B, Bi F-F, Lu X-Q, Wu X-M. Protective effects of quercetin against status epilepticus induced hippocampal neuronal injury in rats: involvement of X-linked inhibitor of apoptosis protein. Acta Neurol Belg. 2011;111(3):205.22141284
   PubMed Web of Science ®Google Scholar
• Lee GH, Lee SJ, Jeong SW, et al. Antioxidative and antiinflammatory activities of quercetin-loaded silica nanoparticles. Colloids Surf B Biointerfaces. 2016;143:511–517. doi:10.1016/j.colsurfb.2016.03.06027038916
   PubMed Web of Science ®Google Scholar
• Ghosh S, Sarkar S, Choudhury ST, Ghosh T, Das N. Triphenyl phosphonium coated nano-quercetin for oral delivery: neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats. Nanomedicine. 2017;13(8):2439–2450. doi:10.1016/j.nano.2017.08.00228822845
   PubMed Web of Science ®Google Scholar
• Ghosh S, Dungdung SR, Chowdhury ST, et al. Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radical Bio Med. 2011;51(10):1893–1902. doi:10.1016/j.freeradbiomed.2011.08.01921914470
   PubMedGoogle Scholar
• Puerta E, Suárez-Santiago JE, Santos-Magalhães NS, Ramirez MJ, Irache JM. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease. Int J Pharm. 2017;517(1–2):50–57. doi:10.1016/j.ijpharm.2016.11.06127915007
   PubMedGoogle Scholar